Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | USP2 | O75604 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL592903 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2837141 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2839053 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL8463541 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2841007 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2836294 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL585734 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2838417 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL816892 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL28416989 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129347-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | California Institute of Technology (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2015157736-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-10-15 | — | — | WO | claimed |
| US-20150284313-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-10-08 | — | — | US | claimed |
| CN-115515989-B | Modified ethylene-vinyl alcohol resin and gas barrier material | 三菱化学株式会社 | 2025-05-27 | — | — | CN | disclosed |
| EP-4502049-A1 | MODIFIED ETHYLENE-VINYL ALCOHOL COPOLYMER COMPOSITION, PELLETS, MULTILAYER STRUCTURE, METHOD FOR PRODUCING MODIFIED ETHYLENE-VINYL ALCOHOL COPOLYMER COMPOSITION, AND METHOD FOR PRODUCING MULTILAYER STRUCTURE | Mitsubishi Chemical Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20240400727-A1 | MODIFIED ETHYLENE-VINYL ALCOHOL COPOLYMER COMPOSITION, PELLETS, MULTILAYER STRUCTURE, METHOD FOR PRODUCING MODIFIED ETHYLENE-VINYL ALCOHOL COPOLYMER COMPOSITION, AND METHOD FOR PRODUCING MULTILAYER STRUCTURE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-12-05 | — | — | US | disclosed |
| CN-118804948-A | Modified ethylene-vinyl alcohol copolymer composition, pellet, multilayer structure, method for producing modified ethylene-vinyl alcohol copolymer composition, and method for producing multilayer structure | 三菱化学株式会社 | 2024-10-18 | — | — | CN | disclosed |
| EP-4438641-A1 | MODIFIED ETHYLENE-VINYL ALCOHOL RESIN COMPOSITION, GAS BARRIER MATERIAL, AND STRETCHED FILM | Mitsubishi Chemical Corporation (JP) | 2024-10-02 | — | — | EP | disclosed |
| US-20240287297-A1 | MODIFIED ETHYLENE-VINYL ALCOHOL RESIN COMPOSITION, GAS-BARRIER MATERIAL, AND STRETCHED FILM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-08-29 | — | — | US | disclosed |
| EP-4421100-A1 | PROCESS FOR PRODUCTION OF ETHYLENE-VINYL ALCOHOL COPOLYMER AND PRODUCTION METHOD FOR ETHYLENE-VINYL ALCOHOL COPOLYMER | Mitsubishi Chemical Corporation (JP) | 2024-08-28 | — | — | EP | disclosed |
| US-20240270886-A1 | ETHYLENE-VINYL ALCOHOL COPOLYMER AND PRODUCTIN METHOD FOR ETHYLENE-VINYL ALCOHOL COPOLYMER | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-08-15 | — | — | US | disclosed |
| CN-102123979-A | Method for synthesizing terminal olefins from internal olefins by olefin metathesis | ELEVANCE RENEWABLE SCIENCES | 2011-07-13 | — | — | CN | disclosed |
| US-20100145086-A1 | Synthesis of Terminal Alkenes From Internal Alkenes Via Olefin Metathesis | ELEVANCE RENEWABLE SCIENCES, INC. | 2010-06-10 | — | — | US | disclosed |
| EP-2076484-A2 | SYNTHESIS OF TERMINAL ALKENES FROM INTERNAL ALKENES VIA OLEFIN METATHESIS | Elevance Renewable Sciences, Inc. (US) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008046106-A2 | SYNTHESIS OF TERMINAL ALKENES FROM INTERNAL ALKENES VIA OLEFIN METATHESIS | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2008-04-17 | — | — | WO | disclosed |
| US-6610733-B2 | Antiestrogen, therapeutic agent for breast cancer | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-08-26 | — | — | US | disclosed |
| US-20030125571-A1 | Optically active chroman and thiochroman derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-07-03 | — | — | US | disclosed |
| US-6552068-B1 | Having anti-estrogenic activity; for use in therapy | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-04-22 | — | — | US | disclosed |
| EP-1241167-A1 | 3-ETHYL-, 3-PROPYL- OR 3-BUTYL-CHROMAN AND -THIOCHROMAN DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-09-18 | — | — | EP | disclosed |
| EP-1241165-A1 | OPTICALLY ACTIVE CHROMAN AND THIOCHROMAN DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125571-A1 | Optically active chroman and thiochroman derivatives | NR5A1, CYP19A1, SHBG | CYP3A4 56/4885MAPT 2959/4885USP2 3858/4885 |
| US-20150284313-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | DDC, LTC4S, CYCS | CYP3A4 31/4885MAPT 4101/4885USP2 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.